45-1086
Mouse Monoclonal Antibody to Nivolumab (Clone : 8G6G3D8)
Abeomics
Image
DESCRIPTION
Nivolumab (Opdivo) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Nivolumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in the activation of T-cell-mediated immune responses against tumor cells. Anti-Nivolumab Antibody (8G6G3D8), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Nivolumab.
DETAILS
- App Id: ELISA
- Isotype: Mouse IgG1
- Format Id: Purified
- Clone Name: 8G6G3D8
- Host Animal: Mouse
- Clonality Id: Monoclonal
- Purification: Protein A chromatography
- Product Content: 0.5 mg/ml, lyophilized with PBS, pH 7.4, containing 0.02% sodium azide.
- Application Note: ELISA detection: 0.01-0.1 µg/ml
- Storage Condition: The antibody is stable in lyophilized form if stored at -20°C or below. The reconstituted antibody can be stored for 2-3 weeks at 2-8°C. For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles.
- Immunogen Information: Nivolumab